P546 Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn’s disease patients (EVOLVE) in Canada: Interim results

Title
P546 Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn’s disease patients (EVOLVE) in Canada: Interim results
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 12, Issue supplement_1, Pages S382-S382
Publisher
Oxford University Press (OUP)
Online
2018-02-02
DOI
10.1093/ecco-jcc/jjx180.673

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation